Manufacturer or GPO Program year 2025 Source: CMS Open Payments

Pfizer Inc.

NY, United States

CMS manufacturer 100000000286

Open in the dashboard

General payments

$513,229,393

2,932,769 payments

Research payments

$4,611,059,125

269,883 payments

Ownership & investment interest

$0

None reported

Through program year 2025, Pfizer Inc. reported paying $513,229,393 in general payments and $4,611,059,125 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $44,497,239 549,896
2025 Research $579,428,043 37,797
2024 General $43,510,452 570,295
2024 Research $630,146,475 36,209
2023 General $36,770,354 515,138
2023 Research $644,319,978 37,899
2022 General $269,538,865 288,544
2022 Research $810,421,076 37,125
2021 General $44,674,069 310,507
2021 Research $770,799,985 43,770
2020 General $28,888,467 189,084
2020 Research $724,145,565 38,066
2019 General $45,349,946 509,305
2019 Research $451,798,004 39,017

Breakdown

Top recipients General payments · program year 2025
  1. Dana-Farber Cancer Institute Teaching hospital · MA $997,905 9 payments
  2. Brigham And Womens Hospital Teaching hospital · MA $658,840 6 payments
  3. Montefiore Medical Center Teaching hospital · NY $544,165 5 payments
  4. Sanjeev Jain Hematology & Oncology · East Patchogue, NY $362,100 21 payments
  5. Hospital Of The Univ Of Penna Teaching hospital · PA $351,727 16 payments
  6. Marc Braunstein Allergy · Hewlett, NY $349,600 15 payments
  7. University Of Iowa Hosp & Clinics Teaching hospital · IA $339,615 16 payments
  8. Shelbi Atrash Hematology & Oncology · Charlotte, NC $307,200 18 payments
  9. Board Of Trustees Of The University Teaching hospital · IL $298,603 3 payments
  10. Moffitt Cancer Center Teaching hospital · FL $293,700 9 payments
Top research recipients Research payments · program year 2025
  1. Ut Md Anderson Cancer Center Teaching hospital · TX $22,374,153 469 payments
  2. Anaheim Clinical Trials LLC $14,365,530 111 payments
  3. Cincinnati Childrens Hospital Medical Center $13,751,199 25 payments
  4. Alliance For Clinical Trials $11,608,063 4 payments
  5. Duke University $10,269,394 162 payments
  6. The Childrens Hospital Of Philadelp Teaching hospital · PA $10,103,322 46 payments
  7. Dana-Farber Cancer Institute Teaching hospital · MA $8,475,460 104 payments
  8. Alliance Foundation Trials LLC $8,046,767 16 payments
  9. Emory University Hospital Teaching hospital · GA $7,760,511 224 payments
  10. Strong Memorial Hospital Teaching hospital · NY $7,515,714 72 payments
Products the payments named General payments · program year 2025
  1. Nurtec Odt Pain $6,386,592 15% · 54,120 recipients
  2. Cibinqo Inflammation & Immunology $4,097,072 10% · 10,237 recipients
  3. Zavzpret Pain $3,407,268 8% · 33,571 recipients
  4. Elrexfio Oncology $2,900,121 7% · 5,036 recipients
  5. Litfulo Immunology $2,830,858 7% · 9,541 recipients

The top 5 of 59 products; each share is of this company’s general payments naming a product in 2025. A payment can name up to five products, so these amounts overlap.

The top 25 products, free in the app

Specialties paid General payments · program year 2025
  1. Dermatology $4,451,839 12% · 4,230 practitioners
  2. Hematology & Oncology Internal Medicine $3,955,537 11% · 3,880 practitioners
  3. Neurology Psychiatry & Neurology $3,219,776 9% · 3,670 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $2,161,908 6% · 21,347 practitioners
  5. Internal Medicine $2,108,993 6% · 13,973 practitioners

The top 5 of 275 specialties; each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $4,692,945 11% · 10,647 recipients
  2. New York $4,450,876 10% · 9,062 recipients
  3. Massachusetts $3,573,699 8% · 1,933 recipients
  4. Florida $2,934,812 7% · 12,713 recipients
  5. Texas $2,736,541 6% · 12,546 recipients

The top 5 of 54 states; each share is of this company’s general payments in 2025 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2019–2025
  1. Acquisitions $260,804,876 67 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $67,724,322 23,240 payments
  3. Consulting Fee $67,565,391 16,835 payments
  4. Food and Beverage $50,734,837 2,826,812 payments
  5. Grant $40,849,512 688 payments
  6. Travel and Lodging $10,587,195 24,185 payments
  7. Honoraria $8,699,120 3,269 payments
  8. Space rental or facility fees (teaching hospital only) $2,127,735 1,200 payments
  9. Royalty or License $2,100,224 76 payments
  10. Charitable Contribution $897,598 63 payments
Companies with a similar name General payments · program years 2019–2025
  1. Pfizer International LLC NY, United States $1,402,022
  2. Pfizer Pharmaceuticals LLC PR, United States $201,484
  3. Pfizer Chile S.A. Chile $78,355
  4. Pfizer Limited Great Britain (UK) $62,745
  5. Pfizer S.A.S. Colombia $19,741
  6. Pfizer S.A. Peru $18,543
  7. Pfizer Canada Inc Canada $2,036
  8. Pfizer Pharma GMBH Germany $2,030
  9. Pfizer Zona Franca, S.A. Costa Rica $1,395
  10. Pfizer Corporation Hong Kong Limited Hong Kong $653

Grouped by name only. CMS publishes no corporate ownership, so a shared name does not mean a shared parent. The largest 10 of 13.

2,932,769 general · 269,883 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record